Participants 136 158 3
advanced breast cancer
Participants 210 262 6
155 consecutive patients with Stage IV breast cancer
Participants 1048 1091 3
patients with more than one metastatic site
Participants 1570 1610 4
estrogen receptor (ER)-negative patients
Participants 1616 1653 4
patients younger than 51 years of age
Participants 1663 1718 4
patients with a disease-free interval of 1 year or less
